Back to search results

First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

Abroad (travel likely)RecruitingPHASE1

Conditions

Lynch Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Laura Burunat, Barcelona, Barcelona, Spain

    Contact: Study coordinator (Laura Burunat, Chemistry) · burunat@recerca.clinic.cat · 0034932275400
    Contact: Principal Investigator (Francesc Balaguer, MDPhD)
    Thomas Walle, MDPhD (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)